PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET ANALYSIS

Market News

Global Peripherally Inserted Central Catheters Market: Key Developments

On March 3, 2020, Access Vascular, Inc., a U.S.-based medical device company that develops novel bulk hydrophilic-based devices to improve venous access, announced it has received U.S. FDA clearance for the second generation of its HydroPICC peripherally inserted central catheter (PICC), which has demonstrated an average of 97% less thrombus accumulation on its surface compared to a standard polyurethane catheter. HydroPICC is comprised of Access Vascular’s patented biomaterial platform that combines the superior mechanical properties of polyurethanes with the intrinsically low thrombogenicity of hydrogel. The lubricious and hydrophilic material is designed to repel protein and thrombus development, prevent catheter occlusion, reduce infections, and add flexibility to the catheter.

On April 12, 2023, BACTIGUARD AB, a Sweden-based global med-tech company, announced the launch of a clinical study to compare the Bactiguard’s infection prevention coating technology (BIP CVC) with a non-coated standard catheter. The endpoints of the study will include, catheter-associated blood stream infections and thrombosis rate. The study will be performed at multiple sites in India. The study has been approved by the local regulatory authorities DCGI (Drug Controller General of India). It will be a randomized, controlled multi-center study that will be conducted over one year with the first patient enrolling in the first half of 2023.

On December 5, 2022, Macmillan Cancer Support, a U.K.-based charity and specialist health care provider to people affected by cancer, launched two brand new support videos for people affected by cancer. 'Having your PICC line put in' and 'Having your central line put in' A PICC line is another name for a tube called a catheter. It is implanted in an arm to deliver chemotherapy and other medications. Similarly, a central line is a tube inserted into a chest vein to do the same job. These videos are to spread awareness on when and why this procedure is needed and what to expect. Such informative videos can raise awareness on use of PICC’s.

On January 23, 2023, Inspira-Technologies OXY B.H.N. LTD., Israel based respiratory support Technology Company, announced that the novel convertible dual lumen cannula device and method of use, being developed for the INSPIRA ART System, has been granted a patent by the U.S. Patent and Trademark Office (USPTO). The patent approval includes 20 claims that were found to be novel, with inventive step and industrial applicability.